These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33155399)

  • 1. Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells.
    Dolinschek R; Hingerl J; Benge A; Zafiu C; Schüren E; Ehmoser EK; Lössner D; Reuning U
    Mol Oncol; 2021 Feb; 15(2):503-522. PubMed ID: 33155399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.
    Carduner L; Picot CR; Leroy-Dudal J; Blay L; Kellouche S; Carreiras F
    Exp Cell Res; 2014 Jan; 320(2):329-42. PubMed ID: 24291221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
    Lössner D; Abou-Ajram C; Benge A; Reuning U
    Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-like protein 2 decreases peritoneal metastasis of ovarian cancer cells by suppressing anoikis resistance.
    Takeshita Y; Motohara T; Kadomatsu T; Doi T; Obayashi K; Oike Y; Katabuchi H; Endo M
    Biochem Biophys Res Commun; 2021 Jul; 561():26-32. PubMed ID: 34000514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin induces ovarian cancer resistance to anoikis by regulating mitochondrial activity.
    Gogola-Mruk J; Tworzydło W; Krawczyk K; Marynowicz W; Ptak A
    Endocrine; 2023 May; 80(2):448-458. PubMed ID: 36658296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy Induction Results in Enhanced Anoikis Resistance in Models of Peritoneal Disease.
    Chen JL; David J; Cook-Spaeth D; Casey S; Cohen D; Selvendiran K; Bekaii-Saab T; Hays JL
    Mol Cancer Res; 2017 Jan; 15(1):26-34. PubMed ID: 27807188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
    Yu X; Liu L; Cai B; He Y; Wan X
    Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2.
    Tang MK; Zhou HY; Yam JW; Wong AS
    Neoplasia; 2010 Feb; 12(2):128-38. PubMed ID: 20126471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic salt bridge formation in integrin αvß3 stabilizes its inactive state affecting integrin-mediated cell biological effects.
    Müller MA; Brunie L; Bächer AS; Kessler H; Gottschalk KE; Reuning U
    Cell Signal; 2014 Nov; 26(11):2493-503. PubMed ID: 25041847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.
    Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O
    Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells.
    Guha D; Saha T; Bose S; Chakraborty S; Dhar S; Khan P; Adhikary A; Das T; Sa G
    Apoptosis; 2019 Dec; 24(11-12):958-971. PubMed ID: 31641961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
    Upheber S; Karle A; Miller J; Schlaugk S; Gross E; Reuning U
    Cell Signal; 2015 Mar; 27(3):652-62. PubMed ID: 25435431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
    Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
    Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21.
    Zhang Y; Yang M; Ji Q; Fan D; Peng H; Yang C; Xiong D; Zhou Y
    Invest New Drugs; 2011 Aug; 29(4):666-73. PubMed ID: 21170668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
    Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK-independent alphavbeta3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts.
    Zoppi N; Barlati S; Colombi M
    Biochim Biophys Acta; 2008 Jun; 1783(6):1177-88. PubMed ID: 18405669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
    Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
    Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
    Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
    J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.
    Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.